🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 2 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/06/2008 | 46,35 | 47,34 | 46,35 | 46,93 | +0,44% | 2,15% | 374.800 |
| 25/06/2008 | 46,31 | 46,81 | 46,14 | 46,73 | +0,94% | 1,46% | 845.800 |
| 24/06/2008 | 46,77 | 47,44 | 46,28 | 46,29 | -1,65% | 2,48% | 810.600 |
| 23/06/2008 | 47,60 | 47,82 | 46,73 | 47,07 | -1,02% | 2,29% | 571.400 |
| 20/06/2008 | 47,42 | 47,75 | 47,06 | 47,55 | -0,34% | 1,47% | 692.200 |
| 19/06/2008 | 47,29 | 47,93 | 47,22 | 47,71 | +0,85% | 1,50% | 614.400 |
| 18/06/2008 | 47,82 | 48,15 | 47,01 | 47,31 | -1,75% | 2,39% | 703.200 |
| 17/06/2008 | 48,46 | 48,52 | 47,95 | 48,16 | -0,75% | 1,17% | 505.200 |
| 16/06/2008 | 47,80 | 48,74 | 47,52 | 48,52 | +1,33% | 2,55% | 713.200 |
| 13/06/2008 | 47,44 | 48,25 | 47,31 | 47,89 | +1,08% | 1,99% | 405.200 |
| 12/06/2008 | 46,97 | 48,28 | 46,61 | 47,38 | +1,37% | 3,57% | 908.800 |
| 11/06/2008 | 47,01 | 47,24 | 46,74 | 46,74 | -0,76% | 1,06% | 544.200 |
| 10/06/2008 | 47,26 | 47,42 | 46,82 | 47,10 | -0,85% | 1,27% | 481.400 |
| 09/06/2008 | 48,12 | 48,23 | 46,78 | 47,50 | -1,33% | 3,02% | 745.600 |
| 06/06/2008 | 48,13 | 48,85 | 47,80 | 48,14 | -0,42% | 2,19% | 584.000 |
| 05/06/2008 | 47,81 | 49,10 | 47,67 | 48,35 | +0,93% | 2,99% | 1.451.600 |
| 04/06/2008 | 46,77 | 48,00 | 46,60 | 47,90 | +1,85% | 3,00% | 807.200 |
| 03/06/2008 | 47,49 | 47,49 | 46,29 | 47,03 | -0,48% | 2,53% | 1.138.400 |
| 02/06/2008 | 47,76 | 47,76 | 46,98 | 47,26 | -1,05% | 1,63% | 935.600 |
| 30/05/2008 | 48,02 | 48,02 | 47,17 | 47,76 | +0,07% | 1,77% | 732.000 |
| 29/05/2008 | 46,89 | 47,99 | 46,51 | 47,72 | +1,87% | 3,15% | 997.800 |
| 28/05/2008 | 47,49 | 47,99 | 46,27 | 46,85 | -0,75% | 3,62% | 1.144.000 |
| 27/05/2008 | 46,17 | 47,35 | 46,04 | 47,20 | +2,55% | 2,85% | 1.551.200 |
| 23/05/2008 | 45,37 | 46,03 | 45,24 | 46,03 | +0,94% | 1,75% | 823.600 |
| 22/05/2008 | 44,65 | 46,12 | 43,50 | 45,60 | +2,52% | 5,86% | 2.266.000 |
| 21/05/2008 | 46,13 | 46,24 | 43,72 | 44,48 | -3,20% | 5,46% | 2.686.000 |
| 20/05/2008 | 46,63 | 47,02 | 45,86 | 45,95 | -1,30% | 2,50% | 1.065.800 |
| 19/05/2008 | 46,38 | 46,98 | 45,63 | 46,55 | +0,55% | 2,90% | 1.569.200 |
| 16/05/2008 | 45,79 | 46,31 | 45,05 | 46,30 | +1,66% | 2,75% | 1.212.800 |
| 15/05/2008 | 46,62 | 46,66 | 45,22 | 45,54 | -2,50% | 3,10% | 1.466.200 |